Gut bacteria in people with HIV or hepatitis B
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study looks at the gut microbiome (the bacteria in your digestive system) in people living with HIV or hepatitis B. By comparing stool samples, researchers hope to understand how these viruses affect gut health, which might lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must have HIV and be on antiretroviral therapy, or have chronic hepatitis B (including related liver problems like cirrhosis or liver cancer).
- You must not have taken antibiotics, steroids, or certain vaginal or skin medications within 24 hours before the stool sample.
- You must not have an acute, moderate-to-severe illness at the time of the sample, or you can reschedule.
- You must not have an uncontrolled gastrointestinal condition that could affect the microbiome analysis.
- You must not be pregnant or breastfeeding at the time of sample collection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
This study looks at how changing your HIV medication affects the bacteria in your gut. You'll provide two stool samples so researchers can see what changes happen.
This study looks at the types of bacteria living in the gut and vagina of women with HIV, including pregnant women. It aims to understand how these bacteria might affect health.
This trial studies how the bacteria in your gut (“microbiome”) relate to frailty (weakness/low physical resilience) in people with HIV who are stably doing well on treatment. It may help researchers understand why some people become frail and how the gut may play a role.
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.